Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Research Shows CBD Benefits 50+ Conditions

Research Shows CBD Benefits 50+ Conditions

Research Shows CBD Benefits 50+ Conditions by Aaron Cadena at CBD Origin

Over the last few years, Cannabidiol (CBD) has exploded into the world of health and wellness.

With dozens of natural benefits, CBD has been used to ease conditions such as anxiety, epilepsy, neurodegenerative diseases and more.

For the last century, researchers have assessed CBD as a treatment for numerous conditions. More than 50, in fact.

What these studies show is profound.

If you are looking for research on CBD benefits for a certain condition, you will find it here.

From mental health to MS, we have gathered a collection of more than 250 resources, organized by condition.

Check out the collection below and feel free to share your thoughts in the comments below.

Studies Reveal CBD Benefits More Than 50 Conditions

Browse Medical Research Based on Condition

51CBD FOR ACNECannabidiol as a Treatment for Acne?
1CBD FOR ACNECannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes
1CBD FOR ACNEThe endocannabinoid system of the skin in health and disease: Novel perspectives and therapeutic opportunities
1CBD FOR ACNEEndocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling
1CBD FOR ACNEEndocannabinoid signaling and epidermal differentiation
62CBD FOR ADD / ADHDSearching for a Neurobiological Basis for Self-Medication Theory in ADHD Comorbid With Substance Use Disorders
2CBD FOR ADD / ADHDCannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague-Dawley rats
2CBD FOR ADD / ADHDSubtypes of Attention Deficit — Hyperactivity Disorder (ADHD) and cannabis use
2CBD FOR ADD / ADHDChildhood and current ADHD symptom dimensions are associated with more severe cannabis outcomes in college students
2CBD FOR ADD / ADHDOral delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: A case report
2CBD FOR ADD / ADHDFitness to drive in spite (because) of THC
103CBD FOR ADDICTIONCannabidiol reduces cigarette consumption in tobacco smokers
3CBD FOR ADDICTIONCannabidiol inhibits the reward-facilitating effect of morphine
3CBD FOR ADDICTIONCannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances
3CBD FOR ADDICTIONDifferential effect of cannabinol and cannabidiol on THC-induced responses during abstinence in morphine-dependent rats
3CBD FOR ADDICTIONImpact of Cannabis Use during Stabilization on Methadone Maintenance Treatment
3CBD FOR ADDICTIONMedical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010
3CBD FOR ADDICTIONDysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents
3CBD FOR ADDICTIONComparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity
3CBD FOR ADDICTIONTransdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder
3CBD FOR ADDICTIONCannabidiol for the treatment of cannabis withdrawal syndrome
44CBD FOR ALSCannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials
4CBD FOR ALSALS: delayed disease progression in mice by treatment with a cannabinoid
4CBD FOR ALSThe (Endo)Cannabinoid System in Multiple Sclerosis and ALS
4CBD FOR ALSSurvey of cannabis use in patients with ALS
165CBD FOR ALZHEIMERSThe therapeutic potential of the endocannabinoid system for Alzheimer’s disease
5CBD FOR ALZHEIMERSEndocannabinoid signalling in Alzheimer’s disease
5CBD FOR ALZHEIMERSA molecular link between the active component of marijuana and Alzheimer’s disease pathology
5CBD FOR ALZHEIMERSNeuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells
5CBD FOR ALZHEIMERSThe Potential Therapeutic Effects of THC on Alzheimer’s Disease
5CBD FOR ALZHEIMERSThe Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer’s Disease
5CBD FOR ALZHEIMERSCannabinoids for the treatment of dementia
5CBD FOR ALZHEIMERSCannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression
5CBD FOR ALZHEIMERSCannabidiol: A promising drug for neurodegenerative disorders?
5CBD FOR ALZHEIMERSCannabinoid receptor 1 deficiency in a mouse model of Alzheimer’s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition
5CBD FOR ALZHEIMERSThe role of the endocannabinoid system in Alzheimer’s disease: facts and hypotheses
5CBD FOR ALZHEIMERSThe role of phytochemicals in the treatment and prevention of dementia
5CBD FOR ALZHEIMERSCannabinoids for the treatment of dementia
5CBD FOR ALZHEIMERSCannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement
5CBD FOR ALZHEIMERSCannabinoids for treatment of Alzheimer’s disease: moving toward the clinic
5CBD FOR ALZHEIMERSCan Marijuana Prevent Alzheimer’s?
46CBD FOR ANOREXIALeptin, ghrelin, and endocannabinoids: Potential therapeutic targets in anorexia nervosa
6CBD FOR ANOREXIAThe role of the endocannabinoid system in eating disorders: Neurochemical and behavioural preclinical evidence
6CBD FOR ANOREXIACancer cachexia and cannabinoids
6CBD FOR ANOREXIABrain Type 1 Cannabinoid Receptor Availability in Patients with Anorexia and Bulimia Nervosa
97CBD FOR ANXIETYCannabidiol, a Cannabis sativa constituent, as an anxiolytic drug
7CBD FOR ANXIETYAntidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis Sativa
7CBD FOR ANXIETYCannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients
7CBD FOR ANXIETYNeural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder
7CBD FOR ANXIETYCentral anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation
7CBD FOR ANXIETYEffects of cannabidiol (CBD) on regional cerebral blood flow
7CBD FOR ANXIETYThe anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors
7CBD FOR ANXIETYThe anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
7CBD FOR ANXIETYPlant-based medicines for anxiety disorders, part 2: A review of clinical studies with supporting preclinical evidence
48CBD FOR ATHEROSCLEROSISThe role of the endocannabinoid system in atherosclerosis
8CBD FOR ATHEROSCLEROSISCannabinoid receptors in atherosclerosis
8CBD FOR ATHEROSCLEROSISThe potential use of cannabidiol in the therapy of metabolic syndrome
8CBD FOR ATHEROSCLEROSISLow dose oral cannabinoid therapy reduces progression of atherosclerosis in mice
49CBD FOR ARTHRITISPreliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis
9CBD FOR ARTHRITISThe nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
9CBD FOR ARTHRITISThe abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55
9CBD FOR ARTHRITISArthritis and cannabinoids
510CBD FOR ASTHMAThe role of cannabinoids in inflammatory modulation of allergic respiratory disorders, inflammatory pain and ischemic stroke
10CBD FOR ASTHMAAllergen challenge increases anandamide in bronchoalveolar fluid of patients with allergic asthma
10CBD FOR ASTHMAActivation of cannabinoid receptors prevents antigen-induced asthma-like reaction in guinea pigs
10CBD FOR ASTHMAEndogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways
10CBD FOR ASTHMABronchodilator effect of delta1-tetrahydrocannabinol
511CBD FOR AUTISMMutations found in individuals with autism interfere with endocannabinoid signaling in the brain
11CBD FOR AUTISMCannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders
11CBD FOR AUTISMA novel approach to the symptomatic treatment of autism
11CBD FOR AUTISMConsequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders
11CBD FOR AUTISMTargeting the endocannabinoid system in the treatment of fragile X syndrome
512CBD FOR BIPOLAR AFFECTIVE DISORDERCannabinoids in bipolar affective disorder: A review and discussion of their therapeutic potential
12CBD FOR BIPOLAR AFFECTIVE DISORDERCannabidiol was ineffective for manic episode of bipolar affective disorder
12CBD FOR BIPOLAR AFFECTIVE DISORDEREffects of Co-occurring Cannabis Use Disorders on the Course of Bipolar Disorder After a First Hospitalization for Mania
12CBD FOR BIPOLAR AFFECTIVE DISORDERDoes Cannabis Use Affect Treatment Outcome in Bipolar Disorder?: A Longitudinal Analysis
12CBD FOR BIPOLAR AFFECTIVE DISORDERThe Use of Cannabis as a Mood Stabilizer in Bipolar Disorder: Anecdotal Evidence and the Need for Clinical Research
513CBD FOR CANCER - GENERALCannabidiol as potential anticancer drug
13CBD FOR CANCER - GENERALCannabidiol inhibits angiogenesis by multiple mechanisms
13CBD FOR CANCER - GENERALThe inhibitory effects of cannabidiol on systemic malignant tumors
13CBD FOR CANCER - GENERALCannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1
13CBD FOR CANCER - GENERALMarijuana fights cancer and helps manage side effects
414CBD FOR CANCER - LUNGCannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1C
14CBD FOR CANCER - LUNGCOX-2 and PPAR-γ confer cannabidiol-induced apoptosis of human lung cancer cells
14CBD FOR CANCER - LUNGDecrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells
14CBD FOR CANCER - LUNGMedia ignored expert’s shocking findings that marijuana helps prevent lung cancer
515CBD FOR CANCER - PROSTATE/COLONTowards the use of non-psychoactive cannabinoids for prostate cancer
15CBD FOR CANCER - PROSTATE/COLONIn Vitro Anticancer Activity of Plant-Derived Cannabidiol on Prostate Cancer Cell Lines
15CBD FOR CANCER - PROSTATE/COLONInduction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent
15CBD FOR CANCER - PROSTATE/COLONChemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer
15CBD FOR CANCER - PROSTATE/COLONInhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol
516CBD FOR CANCER - BREASTAntitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
16CBD FOR CANCER - BREASTCannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy
16CBD FOR CANCER - BREASTPathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
16CBD FOR CANCER - BREASTCannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells
16CBD FOR CANCER - BREASTCannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration
817CBD FOR CANCER - BRAINCannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival
17CBD FOR CANCER - BRAINAntitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines(PubMed)
17CBD FOR CANCER - BRAINSystematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas
17CBD FOR CANCER - BRAINCannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism
17CBD FOR CANCER - BRAINId-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target
17CBD FOR CANCER - BRAINTriggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents
17CBD FOR CANCER - BRAINCannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect
17CBD FOR CANCER - BRAINLocal delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme
418CBD FOR CANCER - LEUKEMIACannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression
18CBD FOR CANCER - LEUKEMIACannabidiol-Induced Apoptosis in Human Leukemia Cells
18CBD FOR CANCER - LEUKEMIACannabidiol Reduces Leukemic Cell Size – But Is It Important?
18CBD FOR CANCER - LEUKEMIATargeting cannabinoid receptors to treat leukemia
419CBD FOR CANCER - SKINAnticancer activity of anandamide in human cutaneous melanoma cells
19CBD FOR CANCER - SKINCannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma-associated herpes virus-infected endothelium (PubMed)
19CBD FOR CANCER - SKINCannabinoid receptors as novel targets for the treatment of melanoma
19CBD FOR CANCER - SKINThe Cannabinoid Receptors Are Required for Ultraviolet-Induced Inflammation and Skin Cancer Development
420CBD FOR CANCER - ENDOCRINEEndocannabinoids in endocrine and related tumours
20CBD FOR CANCER - ENDOCRINEA comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells
20CBD FOR CANCER - ENDOCRINECannabinoids in pancreatic cancer: Correlation with survival and pain
20CBD FOR CANCER - ENDOCRINECannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma
421CBD FOR CANCER - BLADDERTRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer
21CBD FOR CANCER - BLADDERAssociation Between Cannabis Use and the Risk of Bladder Cancer
21CBD FOR CANCER - BLADDERInhibitory Effect of Standardized Cannabis sativaExtract and Its Ingredient Cannabidiol on Rat and Human Bladder Contractility
21CBD FOR CANCER - BLADDERBladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism
422CBD FOR CANCER - PAIN RELIEFMulticenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain
22CBD FOR CANCER - PAIN RELIEFNabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial
22CBD FOR CANCER - PAIN RELIEFMarijuana extract helps prevent chemo pain
22CBD FOR CANCER - PAIN RELIEFAn Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics
1023CBD FOR CROHNS & COLITISCannabidiol in inflammatory bowel diseases: a brief overview
23CBD FOR CROHNS & COLITISCannabis finds its way into treatment of Crohn’s disease
23CBD FOR CROHNS & COLITISCannabidiol reduces intestinal inflammation through the control of neuroimmune axis
23CBD FOR CROHNS & COLITISCannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis
23CBD FOR CROHNS & COLITISThe effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis
23CBD FOR CROHNS & COLITISTopical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice
23CBD FOR CROHNS & COLITISCannabinoids and the gut: New developments and emerging concepts
23CBD FOR CROHNS & COLITISEndocannabinoids and the gastrointestinal tract
23CBD FOR CROHNS & COLITISCannabinoids and gastrointestinal motility: Animal and human studies
23CBD FOR CROHNS & COLITISHergenrather presents study of Crohn’s patients as a template for clinical research on Cannabis
1124CBD FOR DEPRESSIONEndocannabinoid system dysfunction in mood and related disorders
24CBD FOR DEPRESSIONAntidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis Sativa
24CBD FOR DEPRESSIONThe endocannabinoid system and the treatment of mood and anxiety disorders
24CBD FOR DEPRESSIONEndocannabinoid signaling in the etiology and treatment of major depressive illness
24CBD FOR DEPRESSIONAntidepressant-like effects of cannabidiol in mice: Possible involvement of 5-HT1A receptors
24CBD FOR DEPRESSIONPutative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants
24CBD FOR DEPRESSIONAntidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa
24CBD FOR DEPRESSIONCirculating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress
24CBD FOR DEPRESSIONSerum contents of endocannabinoids are correlated with blood pressure in depressed women
24CBD FOR DEPRESSIONThe therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants
24CBD FOR DEPRESSIONAntidepressants and Changes in Concentration of Endocannabinoids and N-Acylethanolamines in Rat Brain Structures
2125CBD FOR ENDOCRINE DISORDERSEndocannabinoid system participates in neuroendocrine control of homeostasis
25CBD FOR ENDOCRINE DISORDERSThe emerging role of the endocannabinoid system in endocrine regulation and energy balance
25CBD FOR ENDOCRINE DISORDERSEndocannabinoids in endocrine and related tumours
25CBD FOR ENDOCRINE DISORDERSRole of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas
25CBD FOR ENDOCRINE DISORDERSThe role of the endocannabinoid system in the neuroendocrine regulation of energy balance
25CBD FOR ENDOCRINE DISORDERSCBD for children with Dravet’s and intractable seizures
25CBD FOR ENDOCRINE DISORDERSReport of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy
25CBD FOR ENDOCRINE DISORDERSMedicinal marijuana stops seizures, brings hope to a little girl
25CBD FOR ENDOCRINE DISORDERSCannabinoids for epilepsy

This post first appeared on My CBD Coupons | Save More On The Best CBD Brands & Products, please read the originial post: here

Share the post

Research Shows CBD Benefits 50+ Conditions